OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Positive influence of gut microbiota on the effects of Korean red ginseng in metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial
Eunhak Seong, Shambhunath Bose, Song-Yi Han, et al.
The EPMA Journal (2021) Vol. 12, Iss. 2, pp. 177-197
Open Access | Times Cited: 21

Showing 21 citing articles:

Gut Microbiota: Therapeutic Targets of Ginseng Against Multiple Disorders and Ginsenoside Transformation
Zhaoqiang Chen, Zepeng Zhang, Jiaqi Liu, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 58

Direct and Indirect Evidence of Effects of Bacteroides spp. on Obesity and Inflammation
Liangliang Wu, Seohyun Park, Hojun Kim
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 438-438
Open Access | Times Cited: 19

Natural products for managing metabolic syndrome: a scoping review
Mohammed Faris Abdulghani, Sadeq AL‐Fayyadh
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7

Ginsenoside F4 Alleviates Skeletal Muscle Insulin Resistance by Regulating PTP1B in Type II Diabetes Mellitus
Yujie Zhao, Yao Liu, Jianjun Deng, et al.
Journal of Agricultural and Food Chemistry (2023) Vol. 71, Iss. 39, pp. 14263-14275
Closed Access | Times Cited: 15

Gut Metagenome as a Potential Diagnostic and Predictive Biomarker in Slow Transit Constipation
Hongliang Tian, Chen Ye, Bo Yang, et al.
Frontiers in Medicine (2022) Vol. 8
Open Access | Times Cited: 21

The interaction between ginseng and gut microbiota
Linxian Zhao, Mingxiu Sui, Tongbo Zhang, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 10

The effect of ginseng supplementation and health outcomes: A GRADE-assessed systematic review and meta-analysis of randomized controlled trials
Xu Huang, Mojtaba Daneshi, Maryam Falahatzadeh, et al.
Journal of Functional Foods (2025) Vol. 129, pp. 106879-106879
Closed Access

New dawn of ginsenosides: regulating gut microbiota to treat metabolic syndrome
Xue Bai, Rongzhan Fu, Jianjun Deng, et al.
Phytochemistry Reviews (2024) Vol. 23, Iss. 4, pp. 1247-1269
Closed Access | Times Cited: 3

Ginseng as a therapeutic target to alleviate gut and brain diseases via microbiome regulation
Hamid Iqbal, Y. K. Kim, Mirim Jin, et al.
Journal of Ginseng Research (2024) Vol. 49, Iss. 1, pp. 12-21
Open Access | Times Cited: 2

New perspective on the immunomodulatory activity of ginsenosides: Focus on effective therapies for post-COVID-19
Yixin Wang, Qin Han, Shuxia Zhang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115154-115154
Open Access | Times Cited: 6

Effect of Fermented Red Ginseng Concentrate Intake on Stool Characteristic, Biochemical Parameters, and Gut Microbiota in Elderly Korean Women
Songhee Lee, Sung‐Hee Jung, Heesang You, et al.
Nutrients (2022) Vol. 14, Iss. 9, pp. 1693-1693
Open Access | Times Cited: 7

Korean Red Ginseng extract treatment prevents post-antibiotic dysbiosis-induced bone loss in mice
Ho Jun Kang, Nicholas J. Chargo, Soumya Chennupati, et al.
Journal of Ginseng Research (2022) Vol. 47, Iss. 2, pp. 265-273
Open Access | Times Cited: 7

The effect of microbiome-modulating therapeutics on glucose homeostasis in metabolic syndrome: A systematic review, meta-analysis, and meta-regression of clinical trials
Ridhima Kaul, Pradipta Paul, Manale Harfouche, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2024) Vol. 18, Iss. 8, pp. 103118-103118
Open Access | Times Cited: 1

Isolation and identification of mucin-degrading bacteria originated from human faeces and their potential probiotic efficacy according to host–microbiome enterotype
Heng Yuan, Junyu Zhou, Nanxin Li, et al.
Journal of Applied Microbiology (2022) Vol. 133, Iss. 2, pp. 362-374
Closed Access | Times Cited: 6

The impact of herbal medicine in regulating intestinal flora on female reproductive disorders
Min Liu, Jin Yan, Yeke Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 6

Microbial Therapy with Indigenous Bacteria: From Idea to Clinical Evidence
Е. И. Ермоленко, Irina Koroleva, А. Н. Суворов
Advances in predictive, preventive and personalised medicine (2023), pp. 251-274
Closed Access | Times Cited: 3

Pro- Pre- and Synbiotic Supplementation and Oxalate Homeostasis in 3 PM Context: Focus on Microbiota Oxalate-Degrading Activity
Ganna Tolstanova, Iryna Akulenko, Tetiana Serhiichuk, et al.
Advances in predictive, preventive and personalised medicine (2023), pp. 335-353
Closed Access | Times Cited: 2

The Effect of Ginseng Supplementation on Lipid Profile: GRADE-assessed Systematic Review and Dose-response Meta-analysis of Randomized Controlled Trials
Seyyed Mostafa Arabi, Mostafa Shahraki-Jazinaki, Maryam Nayyer Abadi, et al.
Current Pharmaceutical Design (2024) Vol. 30, Iss. 26, pp. 2047-2058
Closed Access

Investigation of the Relationship Between Serum Low-Density Lipoprotein Cholesterol Levels with Genetic Polymorphisms, Gut Microbiota, and Nutrition
Asu Şevval Dural, Can Ergün, Murat Urhan
Metabolic Syndrome and Related Disorders (2023) Vol. 22, Iss. 2, pp. 133-140
Closed Access

Page 1

Scroll to top